HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 11-10-2012, 04:00 PM   #21
Mandamoo
Senior Member
 
Mandamoo's Avatar
 
Join Date: Jul 2011
Location: Melbourne, Australia
Posts: 432
Re: TDM-1 results reported @ ASCO annual mtg 2012 now in New England Journal of Medic

5-7years is a long time but I can understand their reasoning. We need to come up with a way to determine what is the best treatment for each person. There are people for whom TDM1 has had no benefit - it may, in the early BC setting be no better than the current treatments - the only way to test that is to do trials. I know of many girls who did the TYkerb instead of Herceptin trial in EBC only to recur (and the results did show it was less effective) - if this had been rushed into treatment, it is more palatable as it is a tablet not chemo etc... where would many women be?

To me the answer is to support personalised medicine research - these guys should be investing in profiling tumors and cross referencing results to determine who it is working for and why.
Just my 2cents worth...
__________________
Amanda xx
40 year old Mum to three gorgeous kids - son 5 and daughters 8 and 11
Wife to my wonderfully supportive husband of 17 years!
22 February 2011 - Diagnosed Early Breast Cancer IDBC Stage2b (ER/PR -ve, Her2+ve +++) - 38 years old
(L) skin sparing mastectomy with tissue expander, axilla clearance (2/14 affected) clear margins.
Fec*3, Taxotere and herceptin*2 - stopped due to secondary diagnosis

June 24 2011 Stage IV - Skin met, axilla node, multiple lung lesions

Bolero3 trial - Navelbine, Hereptin weekly, daily Everolimus/Placebo
February 2012 - July 2012 Tykerb and Xeloda - skin mets resolved, Lungs initially dramatically reduced but growing again
August 2012 (turn 40!) tykerb and herceptin (denied compassionate use of TDM1) while holidaying in Italy!
September 2012 - January 2013 TDM1 as part of the Th3resa trial - lymph nodes resolved, lungs slowly progressing.
January 2013 - herceptin, carboplatin and Perjeta (compassionate access)
April 2013 - Some progression in lungs and lymph nodes - Abraxane, Herceptin and Perjeta
July 2013 - mixed response - dramatic reduction of most lung disease, progression of smaller lung nodules and cervical and hilar nodes - ? Add avastin.
Mandamoo is offline   Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 11:07 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter